Author: Mayla Borba; Fernando de Almeida Val; Vanderson Sousa Sampaio; Marcia Araujo Alexandre; Gisely Cardoso Melo; Marcelo Brito; Maria Mourao; Jose Diego Brito Sousa; djane Baia-da-Silva; Marcus Vinitius Farias Guerra; Ludhmila Hajjar; Rosemary Costa Pinto; Antonio Balieiro; Felipe Gomes Naveca; Mariana Xavier; Alexandre Salomao; Andre Siqueira; Alexandre Schwarzbolt; Julio Henrique Rosa Croda; Mauricio Lacerda Nogueira; Gustavo Romero; Quique Bassat; Cor Jesus Fontes; Bernardino Albuquerque; Claudio Daniel-Ribeiro; Wuelton Monteiro; Marcus Lacerda
Title: Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study) Document date: 2020_4_11
ID: ifxm3j4y_7
Snippet: There is no specific antiviral therapy recommended for the disease caused by SARS-CoV-2 (COVID-19). Recent publications have drawn attention to the possible benefit of chloroquine (CQ). Our study aimed to comprehensively evaluate the safety and efficacy of two different CQ dosages in patients with established severe COVID-19......
Document: There is no specific antiviral therapy recommended for the disease caused by SARS-CoV-2 (COVID-19). Recent publications have drawn attention to the possible benefit of chloroquine (CQ). Our study aimed to comprehensively evaluate the safety and efficacy of two different CQ dosages in patients with established severe COVID-19.
Search related documents:
Co phrase search for related documents- antiviral therapy and CQ chloroquine: 1, 2, 3, 4, 5, 6
- antiviral therapy and CQ chloroquine possible benefit: 1
- antiviral therapy and CQ dosage: 1, 2
- antiviral therapy and efficacy safety: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antiviral therapy and possible benefit: 1, 2, 3
- antiviral therapy and recent publication: 1
- antiviral therapy and SARS cause: 1, 2, 3, 4, 5, 6, 7, 8, 9
- antiviral therapy and SARS cause disease: 1
- attention draw and efficacy safety: 1, 2
- attention draw and SARS cause: 1, 2, 3, 4
- CQ chloroquine and CQ dosage: 1, 2, 3, 4, 5, 6
- CQ chloroquine and efficacy safety: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- CQ chloroquine and possible benefit: 1
- CQ chloroquine and recent publication: 1
- CQ chloroquine and SARS cause: 1, 2
- CQ chloroquine possible benefit and CQ dosage: 1
- CQ chloroquine possible benefit and efficacy safety: 1
- CQ chloroquine possible benefit and possible benefit: 1
- CQ dosage and possible benefit: 1, 2
Co phrase search for related documents, hyperlinks ordered by date